🎉 Congratulations to today's "Daily Best" winners!
Each receives 50 USDT for their outstanding in-depth articles! 👏
📝 Today's winners & articles
@Mr_qiang777 https://www.gate.com/post/status/19028534
@Coinstages https://www.gate.com/zh/post/status/19031206
@PlayerYU https://www.gate.com/zh/post/status/19038966
🔥 The event is heating up — 3 winners are selected daily!
You could be tomorrow's pick! Share your market insights now and win 50 USDT plus official exposure!
👉 Join now: gate.com/post
#GateSquare #DeepCreationCamp #DailyBest
Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside
Revvity (NYSE:RVTY) introduced new discovery and automation platforms at SLAS2026, including high content screening systems, plate readers, and workstations, signaling a deeper push into high throughput drug discovery and lab automation. These launches align with the industry’s demand for more efficient and reproducible research workflows and could strengthen Revvity’s position in genomics and lab automation. Investors will monitor the adoption of these systems, order trends, and potential broader collaborations, while also considering risks such as competition and regulatory pressures.